On the other hand, only one mouse receiving EphA2#1 CAR_LV_Expanded T cells had delayed onset of GvHD symptoms, and all the mice receiving EphA2#1 CAR_LV_Expanded T cells survived the treatment until the termination of the model. This evidence concerns the gene EPHA2 and graft versus host disease.